The Latest Cardiac and Vascular News
NEW YORK, Jan. 5, 2018 /PRNewswire/ — Read the full report: https://www.reportlinker.com/p04534881 The interventional cardiology devices market is expected to reach USD 20.85 billion by 2022 from USD 14.52 billion in 2017, at a CAGR of 7.5%. Factors driving the growth of this market include rising geriatric population, improving healthcare infrastructure, and increasing incidence of CVD. On the […]
CUPERTINO, Calif.–(BUSINESS WIRE)– Sensifree, a medical device company developing advanced RF-based hemodynamic monitoring solutions, announces results of a clinical study showing excellent concordance between the signal morphology of its RF based sensor and invasive arterial line, the standard of care for continuous blood pressure monitoring. Clinical data from the study further […]
Published: Jan 05, 2018 Los Angeles, California, November 26, 2017 – Advanced Bifurcation Systems announced that is it seeking $20 million in new funding from outside investors. The new goal was announced in conjunction with the appointment of new CFO Ken Richards, who brings with him a strong background in both debt […]
SAN CARLOS, Calif.–(BUSINESS WIRE)-–BioCardia, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported filing a second Investigational Device Exemption with the FDA for the CardiAMP Chronic Myocardial Ischemia Trial to treat patients with refractory angina. This second potential indication for CardiAMP investigational cell therapy of […]
PALO ALTO, Calif., Jan. 5, 2018 /PRNewswire-USNewswire/ — ReCor Medical announced today randomization of its 146th, and final, subject in the SOLO cohort of its RADIANCE-HTN study. RADIANCE-HTN, ReCor’s study of its Paradise Renal Denervation System in people with hypertension, involves two study cohorts: “SOLO” – whose subjects are removed from anti-hypertensive […]
Los Angeles, California, November 20, 2017 – Advanced Bifurcation Systems is developing a new procedure that could potentially eliminate the need for open-heart surgery in thousands of patients every year. Their system, which is currently going through trials, could make stenting branched arteries much simpler and less time consuming. It would also […]
TOKYO–(BUSINESS WIRE)– Canon Inc. and Canon Medical Systems Corporation today announced the official corporate name (trade name) change of Canon Group Company Toshiba Medical Systems Corporation to Canon Medical Systems Corporation (hereafter referred to as Canon Medical Systems). Since joining the Canon Group in December 2016, Canon Medical Systems has been undertaking the procedures for obtaining regulatory approval […]
PUNE, India, January 4, 2018 /PRNewswire/ — According to a new market research “Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters (Angiography, IVUS), Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection), IVC Filters, Guidewires) – Global Forecast to 2022“, published by MarketsandMarkets™, the market is expected to reach USD 12.63 Billion by 2022 from USD 9.09 […]
PLEASANTON, Calif., Jan. 4, 2018 /PRNewswire/ — Cerebrotech Medical Systems, an innovative medical device company developing neurotechnology solutions, has received clearance from the Food and Drug Administration, or FDA, for the Cerebrotech Visor, previously known as the CMS-5000™ Intracranial Fluids Monitor™. The clearance includes a broad indication for use as an aid in the […]
MARLBOROUGH, Mass., Jan. 3, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the fourth quarter ended December 31, 2017 on Thursday, February 1, 2018 at 8:00 a.m. EST. The call will be hosted by Mike Mahoney, chairman and chief executive […]
